# Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-scientists-inhibition-specific-enzyme-pancreatic.html) · 2026-11-09 · Medicine
Page: https://themorning.science/story/scientists-identify-inhibition-of-a-specific-enzyme-as-a-promising-target-to-tre-3206ba92e11c289c
Kind: research · Impact: low

## In brief

- A study in The American Journal of Pathology reports that blocking complement factor B (CFB), an enzyme in the alternative complement pathway, halted pancreatic cancer growth.
- The reported effect includes altering the tumour environment, according to the article summary.
- The source describes the finding as a promising target for treatment, not a validated therapy.

## Why it matters

The study points to a specific enzyme as a candidate drug target for pancreatic cancer, a disease with limited treatment options, which may guide future preclinical and clinical work.

## Timeline

- 2026-11-10: Medical Xpress reports the study identifying CFB inhibition as a promising pancreatic cancer target

## Coverage

- [Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer](https://medicalxpress.com/news/2026-11-scientists-inhibition-specific-enzyme-pancreatic.html) — Medical Xpress - latest medical and health news stories, 2026-11-09

Tags: pancreatic cancer, complement factor B, enzyme inhibition, cancer research, drug target

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science